Large Cell Medulloblastoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Large Cell Medulloblastoma

MalaCards integrated aliases for Large Cell Medulloblastoma:

Name: Large Cell Medulloblastoma ¹² ¹⁵ ¹⁷ ⁷⁴

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Neuronal diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:3857

NCIt ⁵¹ C6904

EFO ¹⁷ EFO_0008508

UMLS ⁷⁴ C1266180

Sources

Summaries for Large Cell Medulloblastoma

Disease Ontology : ¹² A medulloblastoma that is characterized by cells that are larger than would be normally expected.

MalaCards based summary : Large Cell Medulloblastoma is related to medulloblastoma and anaplastic/large cell medulloblastoma, and has symptoms including vomiting, gait ataxia and headache. An important gene associated with Large Cell Medulloblastoma is SYP (Synaptophysin), and among its related pathways/superpathways are Pathways in cancer and Gastric cancer. The drugs Etoposide and Etoposide phosphate have been mentioned in the context of this disorder. Affiliated tissues include brain, lung and thyroid, and related phenotype is behavior/neurological.

Sources

Related Diseases for Large Cell Medulloblastoma

Diseases related to Large Cell Medulloblastoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 28)

#	Related Disease	Score	Top Affiliating Genes
1	medulloblastoma	29.7	HGF MYC PAX6 SYP
2	anaplastic/large cell medulloblastoma	12.3
3	venous hemangioma	10.2	MYC SYP
4	cerebral primitive neuroectodermal tumor	10.1	MYC SYP
5	medullomyoblastoma	10.1	MYC SYP
6	infratentorial cancer	10.1	MYC SYP
7	peripheral nervous system neoplasm	10.1	MYC SYP
8	central nervous system cancer	10.1	MYC SYP
9	nervous system cancer	10.1	MYC SYP
10	primary effusion lymphoma	9.9	MET MYC
11	endocrine gland cancer	9.9	MYC SYP
12	alveolar soft part sarcoma	9.9	MET SYP
13	aicardi syndrome	9.8
14	deafness, autosomal recessive 39	9.8	HGF MET
15	deafness, autosomal recessive 97	9.8	HGF MET
16	endometrial squamous cell carcinoma	9.8	HGF MET
17	doxorubicin induced cardiomyopathy	9.8	HGF MET
18	papillary thyroid microcarcinoma	9.8	HGF MET
19	familial renal papillary carcinoma	9.8	HGF MET
20	respiratory system cancer	9.8	MET MYC
21	spindle cell synovial sarcoma	9.8	HGF MET
22	spinal chordoma	9.8	HGF MET
23	gastrointestinal system cancer	9.7	MET MYC
24	salivary gland carcinoma	9.7	HGF MET
25	autosomal recessive non-syndromic sensorineural deafness type dfnb	9.7	HGF MET
26	ewing sarcoma	9.6	MYC PAX6 SYP
27	large intestine cancer	9.5	HGF MET MYC
28	lung cancer	8.9	HGF MET MYC SYP

Graphical network of the top 20 diseases related to Large Cell Medulloblastoma:

Sources

Symptoms & Phenotypes for Large Cell Medulloblastoma

UMLS symptoms related to Large Cell Medulloblastoma:

vomiting, gait ataxia, headache

MGI Mouse Phenotypes related to Large Cell Medulloblastoma:

⁴⁷

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	behavior/neurological	MP:0005386	9.02	MET MYC PAX6 PRDM13 SYP

Sources

Drugs & Therapeutics for Large Cell Medulloblastoma

Drugs for Large Cell Medulloblastoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Etoposide

Approved

Phase 2

33419-42-0

36462

Synonyms:

(−)-etoposide

(-)-Etoposide

121471-01-0

136598-18-0

201594-04-9

33419-42-0

35317-32-9

4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-b-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-β-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)

4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside

4-Demethylepipodophyllotoxin b-D-ethylideneglucoside

4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside

4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside

4-demethylepipodophyllotoxin β-D-ethylideneglucoside

4-Demethylepipodophyllotoxin β-D-ethylideneglucoside

4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside

4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin

51854-34-3

76576-58-4

9-((4,6-O-Ethylidine-b-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one

9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one

9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one

9-((4,6-O-Ethylidine-β-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one

AB00438905

AC1L1FN8

AC1L1VT3

AC1L6246

AC1NR4OG

AC1O4WGG

AC1O7M1N

AC1Q47JJ

alpha-D-Glucopyranosyl isomer etoposide

Ambap33419-42-0

Baxter brand OF etoposide

Baxter oncology brand OF etoposide

Bio1_000489

Bio1_000978

Bio1_001467

BPBio1_000673

BRD-K37798499-001-02-5

Bristol myers brand OF etoposide

Bristol myers squibb brand OF etoposide

Bristol-myers brand OF etoposide

Bristol-myers squibb brand OF etoposide

BSPBio_000611

C01576

CCRIS 2392

Celltop

CHEBI:4911

CHEBI:588795

CHEMBL44657

CID11758093

CID284997

CID3310

CID36462

CID5284558

CID6419930

CID6610299

CPD000112002

D00125

DB00773

DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,

Demethyl epipodophyllotoxin ethylidine glucoside

Demethyl Epipodophyllotoxin Ethylidine Glucoside

Demethyl-epiodophyllotoxin ethylidene glucoside

Demethylepipodophyllotoxin-beta-D-ethylideneglucoside

E0675

E1383_SIGMA

EINECS 251-509-1

Epipodophyllotoxin VP-16213

Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside

Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside

Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)

Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)

Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)

Eposide

Eposin

Eposin, Vepesid, VP-16, Toposar, Etoposide

eto GRY

eto-GRY

Etomedac

ETOP

Etopol

Etopophos

Etopophos (phosphate salt)

Etopos

etoposide

Etoposide

Etoposide (JP15/USP/INN)

Etoposide (VP16)

Etoposide [USAN:INN:BAN:JAN]

Etoposide pierre fabre

Etoposide teva

Etoposide, (5a alpha)-isomer

Etoposide, (5a alpha,9 alpha)-isomer

Etoposide, (5S)-isomer

Etoposide, alpha D glucopyranosyl isomer

Etoposide, alpha-D-glucopyranosyl isomer

Etoposido

Etoposido [INN-Spanish]

etoposido Ferrer farma

Etoposidum

Etoposidum [INN-Latin]

Etosid

Exitop

Ferrer brand OF etoposide

Gry brand OF etoposide

HMS1569O13

HMS2052N05

HMS2089F14

HSDB 6517

I06-0248

KBioSS_002410

Lastet

Lemery brand OF etoposide

LS-1214

Medac brand OF etoposide

MLS000049957

MLS001074951

MLS001424283

MLS002153463

MLS002207239

MLS002222184

MolPort-003-983-431

MolPort-004-905-001

MolPort-004-955-161

NCGC00025056-02

NChemBio.2007.10-comp19

nchembio.573-comp8

nchembio873-comp2

NK 171

Novartis brand OF etoposide

NSC 141540

NSC141540

NSC-141540

Onkoposid

Onkoworks brand OF etoposide

Pharmachemie brand OF etoposide

Pierre fabre brand OF etoposide

Prasfarma brand OF etoposide

Prestwick_211

Prestwick0_000396

Prestwick1_000396

Prestwick2_000396

Prestwick3_000396

Riboposid

Ribosepharm brand OF etoposide

S1225_Selleck

SAM001246880

Sanfer brand OF etoposide

SMR000112002

SPBio_002532

ST056353

Tedec meiji brand OF etoposide

Teva brand OF etoposide

Toposar

trans-Etoposide

UNII-6PLQ3CP4P3

Vepesid

VePesid

VePESID (TN)

Vepesid J

Vepeside

Vépéside sandoz

Vépéside-sandoz

VP 16

VP 16 (pharmaceutical)

VP 16213

VP 16-213

VP-16

VP-16-213

ZINC03830818

ZINC03938684

Zuyeyidal

2

Etoposide phosphate

Phase 2

3

Antineoplastic Agents, Phytogenic

Phase 2

4

Topoisomerase Inhibitors

Phase 2

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas	Recruiting	NCT01857453	Phase 2	carboplatine;Etoposide

Search NIH Clinical Center for Large Cell Medulloblastoma

Sources

Genetic Tests for Large Cell Medulloblastoma

Sources

Anatomical Context for Large Cell Medulloblastoma

MalaCards organs/tissues related to Large Cell Medulloblastoma:

⁴²

Brain, Lung, Thyroid, Salivary Gland

Sources

Publications for Large Cell Medulloblastoma

Articles related to Large Cell Medulloblastoma:

#	Title	Authors	Year
1	Aggressive large cell medulloblastoma extending to the extracranial region in brain-dead state. ( 21533576 )	Miwa T...Ida H	2011
2	Occult leptomeningeal large cell medulloblastoma in an adult. ( 19537136 )	Rushing EJ...Azumi N	2009
3	Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. ( 18059365 )	Li Y...Abounader R	2008
4	Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis. ( 18317693 )	Polydorides AD...Edgar MA	2008
5	Differentiation of classic medulloblastoma into metastatic large cell medulloblastoma with focal rhabdoid differentiation in the absence of posterior fossa recurrence. ( 15759130 )	Donner LR	2005
6	Large-cell medulloblastoma in Aicardi syndrome. Case report and literature review. ( 15534766 )	Palm?r L...Kyllerman M	2004
7	Large-cell medulloblastoma with arrestin-like protein expression. ( 12617187 )	Vincent S...Ruchoux MM	2003
8	Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma. ( 10940769 )	Reardon DA...Kun LK	2000

Sources

Genes for Large Cell Medulloblastoma

Genes related to Large Cell Medulloblastoma (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	SYP	Synaptophysin	Protein Coding	21.26	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
2	MYC	MYC Proto-Oncogene, BHLH Transcription Factor	Protein Coding	20.92	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
3	PAX6	Paired Box 6	Protein Coding	20.57	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
4	HGF	Hepatocyte Growth Factor	Protein Coding	20.01	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
5	MET	MET Proto-Oncogene, Receptor Tyrosine Kinase	Protein Coding	19.92	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
6	PRDM13	PR/SET Domain 13	Protein Coding	16.88	DISEASES inferred ¹⁵

Sources

Variations for Large Cell Medulloblastoma

Sources

Expression for Large Cell Medulloblastoma

Search GEO for disease gene expression data for Large Cell Medulloblastoma.

Sources

Pathways for Large Cell Medulloblastoma

Pathways related to Large Cell Medulloblastoma according to GeneCards Suite gene sharing:

(show all 20)

#	Super pathways	Score	Top Affiliating Genes
1	Pathways in cancer ³⁸	12.48	HGF MET MYC
2	Gastric cancer ³⁸ Show member pathways Breast cancer ³⁸ Hepatocellular carcinoma ³⁸	12.4	HGF MET MYC
3	MAPK signaling pathway ¹ ³⁸	12.39	HGF MET MYC
4	ErbB signaling pathway ¹ ³⁸ Show member pathways EGFR Inhibitor Pathway, Pharmacodynamics ⁶² EGFR tyrosine kinase inhibitor resistance ³⁸ Renal cell carcinoma ³⁸ TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer ¹	12.05	HGF MET MYC
5	G-protein signaling RAC1 in cellular process ²³ Show member pathways CDC42 signaling events ¹ Cytoskeleton remodeling CDC42 in cellular processes ²³ RAC1 signaling pathway ¹	12.04	HGF MET PAX6
6	Immune response IFN alpha/beta signaling pathway ²³ Show member pathways Cytokine Network ⁶⁵ Interferon alpha/beta signaling ⁶⁷ Regulation of IFNA signaling ⁶⁷	11.84	HGF MET MYC
7	Immune response IFN gamma signaling pathway ²³ Show member pathways IFN-gamma pathway ¹	11.7	HGF MET MYC
8	Proteoglycans in cancer ³⁸	11.64	HGF MET MYC
9	Listeria monocytogenes entry into host cells ⁶⁷ Show member pathways E-cadherin signaling events ¹ EGFR downregulation ⁶⁷ InlA-mediated entry of Listeria monocytogenes into host cells ⁶⁷ InlB-mediated entry of Listeria monocytogenes into host cell ⁶⁷ Negative regulation of MET activity ⁶⁷	11.56	HGF MET
10	Neural Stem Cell Differentiation Pathways and Lineage-specific Markers ⁶⁶	11.47	PAX6 SYP
11	Central carbon metabolism in cancer ³⁸	11.35	MET MYC
12	P38 MAPK Signaling Pathway (sino) ⁶⁸	11.32	MYC PAX6
13	Malaria ³⁸	11.18	HGF MET
14	FGF signaling pathway ¹	11.15	HGF MET
15	Signaling events mediated by TCPTP ¹ Show member pathways MET activates PI3K/AKT signaling ⁶⁷	11.06	HGF MET
16	Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers ⁶⁶	11.05	HGF MET MYC PAX6
17	Stabilization and expansion of the E-cadherin adherens junction ¹	11.01	HGF MET
18	Arf6 signaling events ¹	10.9	HGF MET
19	Extracellular vesicle-mediated signaling in recipient cells ¹	10.73	HGF MET
20	Syndecan-1-mediated signaling events ¹	10.19	HGF MET

Sources

GO Terms for Large Cell Medulloblastoma

Biological processes related to Large Cell Medulloblastoma according to GeneCards Suite gene sharing:

(show all 11)

#	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of transcription by RNA polymerase II	GO:0045944	9.71	HGF MET MYC PAX6
2	negative regulation of apoptotic process	GO:0043066	9.49	HGF MYC
3	liver development	GO:0001889	9.48	HGF MET
4	response to wounding	GO:0009611	9.46	MYC PAX6
5	cell proliferation	GO:0008283	9.43	MET MYC
6	MAPK cascade	GO:0000165	9.43	HGF MET MYC
7	positive chemotaxis	GO:0050918	9.37	HGF MET
8	negative regulation of autophagy	GO:0010507	9.32	HGF MET
9	positive regulation of DNA biosynthetic process	GO:2000573	9.16	HGF MYC
10	hepatocyte growth factor receptor signaling pathway	GO:0048012	8.96	HGF MET
11	negative regulation of hydrogen peroxide-mediated programmed cell death	GO:1901299	8.62	HGF MET

Sources

Sources for Large Cell Medulloblastoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia